Center for Biomedical Imaging Research, Department of Biomedical Engineering, Tsinghua University, Beijing 100084, China;
Department of Radiology, University of Washington, Seattle, Washington, USA.
Quant Imaging Med Surg. 2013 Dec;3(6):298-301. doi: 10.3978/j.issn.2223-4292.2013.12.01.
Inflammation plays an important role in atherosclerosis. Given the increasing interest in using in-vivo imaging methods to study the physiology and treatment effects in atherosclerosis, noninvasive intraplaque inflammation quantitative method is needed. Dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) has been proposed and validated to quantitatively characterize atherosclerotic plaque inflammation. Recent studies have optimized the imaging protocol, pharmacokinetic modeling techniques. All of these technical advances further promoted DCE-MRI to clinical investigations in plaque risk assessment and therapeutic response monitor. Although larger clinical studies are still needed, DCE-MRI has been proven to be a promising tool to reveal more about intraplaque inflammation by in vivo quantitative inflammation imaging.
炎症在动脉粥样硬化中起着重要作用。鉴于人们越来越感兴趣地使用体内成像方法来研究动脉粥样硬化中的生理学和治疗效果,因此需要一种非侵入性的斑块内炎症定量方法。动态对比增强(DCE)磁共振成像(MRI)已被提出并验证可定量表征动脉粥样硬化斑块炎症。最近的研究已经优化了成像方案、药代动力学建模技术。所有这些技术进步都进一步推动了 DCE-MRI 在斑块风险评估和治疗反应监测的临床研究中。虽然还需要更大规模的临床研究,但 DCE-MRI 已被证明是一种很有前途的工具,通过体内定量炎症成像来揭示更多关于斑块内炎症的信息。